Promising approaches such as targeting SPARC-mediated nanoparticle uptake, HSF1 and TGF-βRII signaling, or CAF-derived exosomal miRNAs, offer innovative avenues to disrupt tumor–stroma crosstalk. This evidence concerns the gene HSF1 and neoplasm.